Back to search

Associations between MDR1 gene polymorphisms and schizophrenia and therapeutic response to olanzapine in female schizophrenic patients

Data up to Jan 2025

Published2006
Citations84
References64

Total Citations Per Year

Abstract

References (64)

A Simple Sequentially Rejective Multiple Test Procedure

1979 • 20,726 citations

A simple salting out procedure for extracting DNA from human nucleated cells

1988 • 20,341 citations

ANALYZING TABLES OF STATISTICAL TESTS

1989 • 14,038 citations

Analyzing Tables of Statistical Tests

1989 • 5,635 citations

Performing the Exact Test of Hardy-Weinberg Proportion for Multiple Alleles

1992 • 4,934 citations

Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

2000 • 2,358 citations

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

1989 • 1,744 citations

Identification of functionally variant MDR1 alleles among European Americans and African Americans

2001 • 1,000 citations

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins

1997 • 934 citations

Textbook of Psychiatry

1976 • 925 citations

Role of P-Glycoprotein in Pharmacokinetics

2003 • 897 citations

Synopsis of Psychiatry

1991 • 877 citations

Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects

2001 • 757 citations

Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1

2003 • 653 citations

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

2003 • 646 citations

Passive Permeability and P-Glycoprotein-Mediated Efflux Differentiate Central Nervous System (CNS) and Non-CNS Marketed Drugs

2002 • 590 citations

Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm

1996 • 578 citations

Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

2000 • 573 citations

A Novel Model of Inflammatory Bowel Disease: Mice Deficient for the Multiple Drug Resistance Gene,mdr1a, Spontaneously Develop Colitis

1998 • 570 citations

Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene.

2001 • 538 citations

Multidrug resistance: molecular mechanisms and clinical relevance

1997 • 516 citations

Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy

2002 • 479 citations

The Environment and Schizophrenia: The Role of Cannabis Use

2005 • 434 citations

Overexpression of Multiple Drug Resistance Genes in Endothelial Cells from Patients with Refractory Epilepsy

2001 • 432 citations

Role of Multidrug Transporters in Pharmacoresistance to Antiepileptic Drugs

2002 • 409 citations

The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells

2001 • 377 citations

MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects.

2001 • 319 citations

Modulation of steady‐state kinetics of digoxin by haplotypes of the P‐glycoprotein MDR1 gene

2002 • 307 citations

Inhibition of P-Glycoprotein by Newer Antidepressants

2003 • 290 citations

Potential Role of Drug Transporters in the Pathogenesis of Medically Intractable Epilepsy

2005 • 283 citations

Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations

2002 • 281 citations

Opiate-induced Analgesia Is Increased and Prolonged in Mice Lacking P-glycoprotein

2000 • 270 citations

Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects

2002 • 266 citations

In vitro P-glycoprotein affinity for atypical and conventional antipsychotics

2002 • 259 citations

The Significance of Age of Onset for Schizophrenia

1992 • 245 citations

Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases

2005 • 245 citations

A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression

2002 • 204 citations

Lack of Association between the C3435T Polymorphism in the Human Multidrug Resistance (MDR1) Gene and Response to Antiepileptic Drug Treatment

2005 • 194 citations

A systematic review of atypical antipsychotic drugs in schizophrenia

2003 • 182 citations

Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene

2002 • 180 citations

Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana

2006 • 180 citations

Clinical Aspects of the MDR1 (ABCB1) Gene Polymorphism

2004 • 180 citations

Interactions between the cytochrome P450 system and the second-generation antipsychotics.

2003 • 165 citations

The MDR1 (ABCB1) Gene Polymorphism and its Clinical Implications

2004 • 165 citations

The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells

2006 • 147 citations

Cytochrome P450 in the Brain ; A Review

2001 • 137 citations

Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds — implications for pharmacokinetics of selected substrates

2004 • 135 citations

Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: Racial differences in bioavailability

1992 • 126 citations

abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice

2003 • 125 citations

Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein

2006 • 118 citations

Blood–brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls

2006 • 86 citations

Olanzapine Penetration into Brain is Greater in Transgenic Abcb1a P-glycoprotein-Deficient Mice than FVB1 (Wild-Type) Animals

2003 • 79 citations

Clinical outcome and olanzapine plasma levels in acute schizophrenia

2004 • 78 citations

Lack of association between C3435T nucleotide MDR1 genetic polymorphism and multidrug-resistant epilepsy

2006 • 77 citations

Frequency Distribution of C3435T Mutation in Exon 26 of the MDR1 Gene in a Spanish Population

2003 • 75 citations

Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999

2006 • 69 citations

Sex differences in age at first hospital admission for schizophrenia: fact or artifact?

1981 • 67 citations

CYP2D in the Brain

2003 • 65 citations

Genetically determined differences in P-glycoprotein function: implications for disease risk

2002 • 60 citations

Frequency of common MDR1 gene variants in a Polish population.

2006 • 56 citations

Regional Expression of Multidrug Resistance Genes in Genetically Epilepsy‐prone Rat Brain after a Single Audiogenic Seizure

2002 • 49 citations

Association between multidrug resistance 1 (MDR1) gene polymorphisms and therapeutic response to bromperidol in schizophrenic patients: A preliminary study

2006 • 46 citations

METABOLIC INTERACTION BETWEEN CYCLOSPORINE AND SIROLIMUS

2004 • 27 citations

Acute-phase treatment in general hospitals: clinical psychopharmacologic evaluation in first-episode schizophrenia patients

2003 • 15 citations

Cited By (0)

Loading...